|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HPV Genotypes 16, 18/45, Anal-Rectal
Test Code92807
CPT Codes
87625
Preferred Specimen
3 mL Dacron/Polyester swab collected in Liquid Cytology (PreservCyt®) Preservative (ThinPrep®)
Minimum Volume
1.5 mL
Instructions
To collect an anal-rectal sample, a wetted, non-lubricated Dacron/Polyester swab is used. The Dacron/Polyester swab is inserted about 3 cm (or until resistance is met) into the anal canal past the anal verge, into the rectal vault. This is done without visualization of the anal canal. Firm lateral pressure is applied to the swab handle as it is rotated and slowly moved in and out. Slowly withdraw swab from the anal canal. Swish the swab vigorously in PreservCyt® fluid in the ThinPrep® vial. Discard the swab. Cap and tighten the ThinPrep® vial.
Follow the same procedure if using a brush to collect an anal-rectal sample. Avoid using cotton swab on a wooden stick because the handle may break and splinter during collection. Swab that is grossly contaminated with feces should be discarded and the collection repeated.
Follow the same procedure if using a brush to collect an anal-rectal sample. Avoid using cotton swab on a wooden stick because the handle may break and splinter during collection. Swab that is grossly contaminated with feces should be discarded and the collection repeated.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 30 days
Refrigerated: 28 days
Frozen: Unacceptable
Refrigerated: 28 days
Frozen: Unacceptable
Methodology
Transcription-Mediated Amplification (TMA)
FDA Status
The analytical performance characteristics of this assay have been determined by Quest Diagnostics. The modifications have not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon, Wed, Fri; Report available: 3-6 days
Reference Range
Not detected
Clinical Significance
Assay is used in combination with anal and rectal cytology to assess the presence or absence of high-risk HPV genotypes 16, 18, and/or 45. This information together with physician's assessment of cytology history, other risk factors and professional guidelines, may be used to guide patient management.
